Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg

FDA Drug Profile — Doxylamine Succinate and Pyridoxine Hydrochloride

Drug Details

Generic Name
Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg
Brand Names
Doxylamine Succinate and Pyridoxine Hydrochloride
Application Number
ANDA208518
Sponsor
Bryant Ranch Prepack
NDC Codes
3
Dosage Forms
TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients
DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. Limitations of Use Doxylamine succinate and pyridoxine hydrochloride delayed-release tablet has not been studied in women with hyperemesis gravidarum. Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are a fixed dose combination drug product of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a Vitamin B6 analog, indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. (1)